Search Results
), tetracycline (30 μg), chloramphenicol (30 μg), trimethoprim/sulphamethoxazole (1.25/23.75 μg), levofloxacin (5 μg), linezolid (10 μg), tigecycline (15 μg), and the susceptibility to vancomycin determined by MIC (broth microdilution test). The antimicrobial
E. Calderaro 2005 Effects of gamma-irradiation on trehalose-hydroxyethylcellulose microspheres loaded with vancomycin Eur J Pharm Biopharm 59
/ ). The antibiotics tested were tetracycline, clindamycin, erythromycin, ciprofloxacin, gentamycin, tobramycin, mupirocin, linezolid, trimethoprim–sulfamethoxazole, teicoplanin, vancomycin, and netilmicin. Since 2011, the susceptibility to vancomycin has
vancomycin hydrochloride on Staphylococcus epidermidis biofilm associated with silicone elastomer Antimicrob Agents Chemother 31 889 894 . 33
: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection. Aliment Pharmacol Ther. 2015; 41: 835
, cefotaxime, ceftriaxone, vancomycin (Liofilchem). (2) N. meningitidis : Discs : chloramphenicol (30 µg), rifampin (5 µg) (Oxoid). MIC: penicillin G, amoxicillin, cefotaxime, ceftriaxone, ciprofloxacin (Liofilchem). (3) H. influenzae type b : Discs
cefoxitin. A urinary tract infection caused by W. virosa was outlined by Meharwal et al. [ 9 ]. Manogaran et al. [ 10 ] described pneumonia and sepsis in a 53-year-old female patient where cefepime/vancomycin treatment had been failed, resulting in patient
prevent further embolisms. Empiric antibiotherapy with vancomycin (30 mg/kg/day intravenous) and gentamicin (3 mg/kg/day intravenous) was started just after taking blood samples for aerobic and anaerobic cultures. Coagulase negative Staphylococcus aureus
-dose vancomycin combined with Saccharomyces boulardii. Clin. Infect. Dis., 2000, 31 , 1012–1017. Greenberg R. N. The search for a better treatment for recurrent Clostridium difficile
awareness require emerging Enterococcus faecium (vancomycin-resistant enterococci [VRE]), Staphylococcus aureus (methicillin-resistant [MRSA], vancomycin-intermediate [VISA], and vancomycin-resistant strains), Helicobacter pylori (clarithromycin
